The sources told PTI that the Pune-based drug firm submitted its application to the DCGI on Friday seeking permission for conducting the trials of #39;Covidshield#39;.from Moneycontrol Business News https://ift.tt/39DHPtD
Saturday, July 25, 2020
Serum Institute of India seeks DCGI permission for phase 2/3 clinical trials of Oxford#39;s COVID #39;vaccine#39;
The sources told PTI that the Pune-based drug firm submitted its application to the DCGI on Friday seeking permission for conducting the trials of #39;Covidshield#39;.from Moneycontrol Business News https://ift.tt/39DHPtD
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment